Symbol="ZLAB"
AssetType="Common Stock"
Name="Zai Lab Ltd"
Description="Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops and markets therapies to treat cancer, autoimmune and infectious diseases in China. The company is headquartered in Shanghai, China."
CIK="1704292"
Exchange="NASDAQ"
Currency="USD"
Country="China"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="4560 JINKE ROAD, BLDG. 1, 4F, PUDONG, SHANGHAI, CHINA"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="2868293000"
EBITDA="-385244000"
PERatio="None"
PEGRatio="None"
BookValue="10.39"
DividendPerShare="0"
DividendYield="0"
EPS="-4.59"
RevenuePerShareTTM="2.409"
ProfitMargin="-1.774"
OperatingMarginTTM="-1.705"
ReturnOnAssetsTTM="-0.184"
ReturnOnEquityTTM="-0.355"
RevenueTTM="231113000"
GrossProfitTTM="-145386000"
DilutedEPSTTM="-4.59"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.344"
AnalystTargetPrice="78.72"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="17.13"
PriceToBookRatio="3.106"
EVToRevenue="12.53"
EVToEBITDA="-4.723"
Beta="1.083"
num_52WeekHigh="53.95"
num_52WeekLow="20.98"
num_50DayMovingAverage="31.36"
num_200DayMovingAverage="34.3"
SharesOutstanding="98389000"
DividendDate="None"
ExDividendDate="None"
symbol="ZLAB"
open="28.70"
high="29.32"
low="28.57"
price="28.98"
volume="390658.00"
latest_trading_day="2023-07-07"
previous_close="28.04"
change="0.94"
change_percent="3.3345%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="69"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="31"
Volume_recent_avg="616143"
Change_recent_avg="-0.1"
Delta_recent_avg="1.8"
Variance_recent_avg="0.9"
Change_ratio_recent_avg="-0.39"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="31"
Aroon_momentum_negative="69"
image_negative_thumbnail_id_1="1140"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0173.jpeg"
image_negative_thumbnail_id_2="1098"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0131.jpeg"
image_neutral_thumbnail_id_1="542"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_neutral_thumbnail_id_2="598"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_positive_thumbnail_id_1="684"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0024.jpeg"
image_positive_thumbnail_id_2="688"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0020.jpeg"
image_professor_thumbnail_id_1="1189"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
